| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1025842663 |
| P356 | DOI | 10.1007/S10549-014-2852-7 |
| P8608 | Fatcat ID | release_kswbmjkzwbhhreczwt3rjkz6xa |
| P932 | PMC publication ID | 4026199 |
| P698 | PubMed publication ID | 24477977 |
| P50 | author | Richard Schwab | Q91187033 |
| P2093 | author name string | Maria Elena Martinez | |
| Kristin N Anderson | |||
| P2860 | cites work | Global cancer statistics | Q22241238 |
| The epidemiology of triple-negative breast cancer, including race | Q24289471 | ||
| Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers | Q24598482 | ||
| Risk factors for triple-negative breast cancer in women under the age of 45 years | Q24644075 | ||
| Cancer statistics, 2013 | Q27860762 | ||
| Timing of menarche and first full-term birth in relation to breast cancer risk | Q37244312 | ||
| Breast cancer risk factors defined by estrogen and progesterone receptor status: the multiethnic cohort study | Q37305988 | ||
| Reproductive factors and risk of premenopausal breast cancer by age at diagnosis: are there differences before and after age 40? | Q37362781 | ||
| Breast cancer risk and hormone receptor status in older women by parity, age of first birth, and breastfeeding: a case-control study | Q37369236 | ||
| What can we learn about disease etiology from case-case analyses? Lessons from breast cancer | Q37792653 | ||
| Pathological and molecular diagnosis of triple-negative breast cancer: a clinical perspective | Q38046575 | ||
| Biological subtypes of triple-negative breast cancer are associated with distinct morphological changes and clinical behaviour | Q42440577 | ||
| Differences in risk factors for breast cancer molecular subtypes in a population-based study | Q42509874 | ||
| Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry | Q42510173 | ||
| Association between common risk factors and molecular subtypes in breast cancer patients | Q42512756 | ||
| Association between chronological change of reproductive factors and breast cancer risk defined by hormone receptor status: results from the Seoul Breast Cancer Study | Q43527322 | ||
| Are colorectal cancer screening recommendations for first-degree relatives of patients with adenomas too aggressive? | Q44167448 | ||
| Reproductive and hormonal risk factors for luminal, HER2-overexpressing, and triple-negative breast cancer in Japanese women. | Q44476497 | ||
| Reproductive and hormonal factors, family history, and breast cancer according to the hormonal receptor status. | Q50865101 | ||
| Triple-negative breast cancer in Hispanic patients: high prevalence, poor prognosis, and association with menopausal status, body mass index, and parity. | Q51050853 | ||
| Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update | Q57130157 | ||
| Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype | Q28271274 | ||
| Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study | Q28281843 | ||
| Compared with nibbling, neither gorging nor a morning fast affect short-term energy balance in obese patients in a chamber calorimeter | Q28315007 | ||
| Triple-Negative Breast Cancer | Q29391607 | ||
| American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer | Q30494798 | ||
| Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger | Q30541773 | ||
| Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data | Q30620889 | ||
| Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women's contraceptive and reproductive experiences study | Q33596695 | ||
| Hypothesized role of pregnancy hormones on HER2+ breast tumor development | Q33745434 | ||
| Soluble human epidermal growth factor receptor 2 (HER2) levels in patients with HER2-positive breast cancer receiving chemotherapy with or without trastuzumab: results from North Central Cancer Treatment Group adjuvant trial N9831 | Q34020878 | ||
| Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort | Q34048111 | ||
| Global patterns of cancer incidence and mortality rates and trends | Q34127168 | ||
| Breast feeding, parity and breast cancer subtypes in a Spanish cohort | Q34336498 | ||
| Reproductive history and risk of three breast cancer subtypes defined by three biomarkers | Q34590295 | ||
| A case-control study of reproductive factors associated with subtypes of breast cancer in Northeast China | Q34612076 | ||
| Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study | Q34613673 | ||
| Epidemiology of basal-like breast cancer | Q34639174 | ||
| Triple-negative breast cancer: clinical features and patterns of recurrence | Q34658655 | ||
| Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer | Q34677207 | ||
| Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies | Q35022847 | ||
| Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study | Q35062955 | ||
| Association of hormone-related characteristics and breast cancer risk by estrogen receptor/progesterone receptor status in the shanghai breast cancer study | Q35195576 | ||
| Parity and lactation in relation to estrogen receptor negative breast cancer in African American women | Q35229557 | ||
| Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies | Q35605749 | ||
| Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer | Q35613614 | ||
| Triple negative breast cancer: unmet medical needs | Q35630269 | ||
| Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS) | Q36168475 | ||
| Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study | Q36245367 | ||
| Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20-44 years of age. | Q36542202 | ||
| Estrogen receptor positive tumors: do reproductive factors explain differences in incidence between black and white women? | Q36698673 | ||
| Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors | Q36720821 | ||
| Identification of prognosis-relevant subgroups in patients with chemoresistant triple-negative breast cancer | Q36847243 | ||
| Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO). | Q36924486 | ||
| Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer | Q36984430 | ||
| Reproductive factors, heterogeneity, and breast tumor subtypes in women of mexican descent | Q37237552 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| P304 | page(s) | 1-10 | |
| P577 | publication date | 2014-01-30 | |
| P1433 | published in | Breast Cancer Research and Treatment | Q326085 |
| P1476 | title | Reproductive risk factors and breast cancer subtypes: a review of the literature | |
| P478 | volume | 144 |
| Q36109274 | 4-IHC classification of breast cancer subtypes in a large cohort of a clinical cancer registry: use in clinical routine for therapeutic decisions and its effect on survival |
| Q37533382 | A Matched Case-Control Study of Risk Factors for Breast Cancer Risk in Vietnam |
| Q92969345 | A Pooled Analysis of Breastfeeding and Breast Cancer Risk by Hormone Receptor Status in Parous Hispanic Women |
| Q93103805 | A case-control evaluation of 143 single nucleotide polymorphisms for breast cancer risk stratification with classical factors and mammographic density |
| Q64259241 | A case-control study of Metallothionein-1 expression in breast cancer and breast fibroadenoma |
| Q90609208 | Air Pollution, Clustering of Particulate Matter Components, and Breast Cancer in the Sister Study: A U.S.-Wide Cohort |
| Q36468547 | Alcohol and breast cancer tumor subtypes in a Spanish Cohort |
| Q92633975 | Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer |
| Q27300459 | Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State. |
| Q40487038 | Associations of parity-related reproductive histories with ER± and HER2± receptor-specific breast cancer aetiology |
| Q37733409 | BMI, reproductive factors, and breast cancer molecular subtypes: A case-control study and meta-analysis |
| Q57177086 | Black-White Breast Cancer Incidence Trends: Effects of Ethnicity |
| Q36331017 | Breast cancer in Asian Americans in California, 1988-2013: increasing incidence trends and recent data on breast cancer subtypes |
| Q37608623 | Breast cancer in Mongolia: an increasingly important health policy issue. |
| Q52653871 | Breast cancer in Portugal: Temporal trends and age-specific incidence by geographic regions. |
| Q47169220 | Breast cancer is associated to impaired glucose/insulin homeostasis in premenopausal obese/overweight patients. |
| Q58725493 | Breast cancer risk factors, survival and recurrence, and tumor molecular subtype: analysis of 3012 women from an indigenous Asian population |
| Q50105670 | Breast health in developing countries. |
| Q47736183 | Breastfeeding and Breast Cancer Risk Reduction: Implications for Black Mothers |
| Q28085555 | Breastfeeding and breast cancer risk by receptor status--a systematic review and meta-analysis |
| Q36009818 | Breastfeeding, PAM50 tumor subtype, and breast cancer prognosis and survival |
| Q40476421 | Clinical Considerations of Risk, Incidence, and Outcomes of Breast Cancer in Sexual Minorities. |
| Q92618058 | Clinicopathologic characteristics of HER2-positive pure mucinous breast carcinoma: a systematic investigation into an unusual tumor |
| Q92357783 | Clinicopathological and epidemiological significance of breast cancer subtype reclassification based on p53 immunohistochemical expression |
| Q38683139 | Contribution of clinical and socioeconomic factors to differences in breast cancer subtype and mortality between Hispanic and non-Hispanic white women. |
| Q93016733 | Denosumab and breast cancer risk in postmenopausal women: a population-based cohort study |
| Q92989791 | Dietary index scores and invasive breast cancer risk among women with a family history of breast cancer |
| Q93085976 | Differences in Genome-wide DNA Methylation Profiles in Breast Milk by Race and Lactation Duration |
| Q49992737 | Differences in breast cancer incidence among young women aged 20-49 years by stage and tumor characteristics, age, race, and ethnicity, 2004-2013. |
| Q38698075 | Differential Association of the Lifestyle-Related Risk Factors Smoking and Obesity with Triple Negative Breast Cancer in a Brazilian Population |
| Q40518502 | Differential Patterns of Risk Factors for Early-Onset Breast Cancer by ER Status in African American Women. |
| Q58698569 | Differential effect of parity on rat mammary carcinogenesis after pre- or post-pubertal exposure to radiation |
| Q40373624 | Do racial differences exist in the association between pregnancy-induced hypertension and breast cancer risk? |
| Q47638270 | Does levonorgestrel-releasing intrauterine system increase breast cancer risk in peri-menopausal women? An HMO perspective. |
| Q34621664 | Early pregnancy sex steroids and maternal breast cancer: a nested case-control study |
| Q34477879 | Effects of age on the detection and management of breast cancer. |
| Q36416307 | Elevated risks of subsequent endometrial cancer development among breast cancer survivors with different hormone receptor status: a SEER analysis |
| Q46035896 | Endogenous sex hormone exposure and repetitive element DNA methylation in healthy postmenopausal women. |
| Q36652833 | Epidemiological risk factors associated with inflammatory breast cancer subtypes |
| Q92916929 | Epidemiology of Breast Cancer in Women |
| Q92058631 | Epigenetic mortality predictors and incidence of breast cancer |
| Q33729336 | Estrogen Effects on the Mammary Gland in Early and Late Life and Breast Cancer Risk |
| Q36187913 | Estrogen withdrawal, increased breast cancer risk and the KRAS-variant. |
| Q40277712 | Examining the common aetiology of serous ovarian cancers and basal-like breast cancers using double primaries |
| Q91994065 | Expression of matrix metalloproteinase 2 and 9 in breast cancer and breast fibroadenoma: a randomized, double-blind study |
| Q30620701 | Family history of breast and ovarian cancer and triple negative subtype in hispanic/latina women |
| Q37226242 | Features of triple-negative breast cancer: Analysis of 38,813 cases from the national cancer database |
| Q37347952 | Five year change in alcohol intake and risk of breast cancer and coronary heart disease among postmenopausal women: prospective cohort study |
| Q90393213 | Genomic alterations associated with HER2+ breast cancer risk and clinical outcome in response to trastuzumab |
| Q36547888 | Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers |
| Q38748794 | High density of CD204-positive macrophages predicts worse clinical prognosis in patients with breast cancer. |
| Q64233012 | Higher Breast Cancer Risk Among Immigrant Asian American Women Than Among US-Born Asian American Women |
| Q41183501 | Human Chorionic Gonadotropin and Breast Cancer |
| Q49412994 | Identification of differentially expressed genes in human breast cancer cells induced by 4-hydroxyltamoxifen and elucidation of their pathophysiological relevance and mechanisms. |
| Q28550925 | Imaging Sites of Inhibition of Proteolysis in Pathomimetic Human Breast Cancer Cultures by Light-Activated Ruthenium Compound |
| Q36812955 | Important Role of Menarche in Development of Estrogen Receptor-Negative Breast Cancer in African American Women |
| Q47140277 | Incidence of breast cancer in Chinese women exposed to the 1959-1961 great Chinese famine |
| Q40995588 | Increased risk of tumor in DM1 is not related to exposure to common lifestyle risk factors. |
| Q36853315 | Interaction between APC and Fen1 during breast carcinogenesis |
| Q96302976 | Key steps for effective breast cancer prevention |
| Q40078894 | Lack of Breastfeeding History in Parous Women with Inflammatory Breast Cancer Predicts Poor Disease-Free Survival |
| Q33731195 | Lin28B expression correlates with aggressive clinicopathological characteristics in breast invasive ductal carcinoma |
| Q54504456 | Long-term benefits and risks of HRT (Section 11): Breast cancer. |
| Q89852572 | Mediterranean dietary pattern is associated with lower incidence of premenopausal breast cancer in the Seguimiento Universidad de Navarra (SUN) Project |
| Q58601965 | Menopausal Hormone Therapy use and breast cancer risk by receptor subtypes: Results from the New South Wales Cancer Lifestyle and EvaluAtion of Risk (CLEAR) study |
| Q39510045 | Metrics for monitoring cancer inequities: residential segregation, the Index of Concentration at the Extremes (ICE), and breast cancer estrogen receptor status (USA, 1992-2012). |
| Q33559178 | Molecular Signaling of Progesterone, Growth Hormone, Wnt, and HER in Mammary Glands of Dogs, Rodents, and Humans: New Treatment Target Identification |
| Q38605681 | Molecular insights into the aetiology of female reproductive ageing. |
| Q48610803 | Night Shift Work and Risk of Breast Cancer |
| Q39850850 | Night work and breast cancer risk defined by human epidermal growth factor receptor-2 (HER2) and hormone receptor status: A population-based case-control study in France |
| Q35634515 | Obesity, body fat distribution, and risk of breast cancer subtypes in African American women participating in the AMBER Consortium |
| Q27003364 | On the apparent rarity of epithelial cancers in captive chimpanzees |
| Q36273402 | Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort |
| Q39095124 | Oxidative Stress and Carcinogenesis: Potential of Phytochemicals in Breast Cancer Therapy. |
| Q64101448 | Parity, breastfeeding, and breast cancer risk by hormone receptor status and molecular phenotype: results from the Nurses' Health Studies |
| Q57178558 | Perception matters: Stressful life events increase breast cancer risk |
| Q37168300 | Polycystic ovarian syndrome (PCOS), related symptoms/sequelae, and breast cancer risk in a population-based case-control study |
| Q57025247 | Pooled Analysis of Nine Cohorts Reveals Breast Cancer Risk Factors by Tumor Molecular Subtype |
| Q38984143 | Population-Attributable Risk Proportion of Clinical Risk Factors for Breast Cancer |
| Q28067818 | Potential of breastmilk analysis to inform early events in breast carcinogenesis: rationale and considerations |
| Q40248157 | Potentially functional variants in lncRNAs are associated with breast cancer risk in a Chinese population. |
| Q92727496 | Prediagnostic Immune Cell Profiles and Breast Cancer |
| Q60106091 | Pro-inflammatory cytokines and growth factors in human milk: an exploratory analysis of racial differences to inform breast cancer etiology |
| Q48212165 | Progestin-only and combined oral contraceptives and receptor-defined premenopausal breast cancer risk: The Norwegian Women and Cancer Study |
| Q35832508 | Prolonged use of human insulin increases breast cancer risk in Taiwanese women with type 2 diabetes. |
| Q40118179 | Proportion of premenopausal and postmenopausal breast cancers attributable to known risk factors: Estimates from the E3N-EPIC cohort |
| Q38875616 | Quercetin regulates β-catenin signaling and reduces the migration of triple negative breast cancer |
| Q36415317 | Reproductive factors, tumor estrogen receptor status and contralateral breast cancer risk: results from the WECARE study |
| Q48250088 | Reproductive history, breast-feeding and risk of triple negative breast cancer: The Breast Cancer Etiology in Minorities (BEM) study. |
| Q45951126 | Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study. |
| Q37594136 | Reproductive risk factors in relation to molecular subtypes of breast cancer: Results from the nurses' health studies |
| Q47105002 | Risk Reduction of Breast Cancer by Childbirth, Breastfeeding, and Their Interaction in Korean Women: Heterogeneous Effects Across Menopausal Status, Hormone Receptor Status, and Pathological Subtypes |
| Q39079754 | Risk factors of breast cancer and knowledge about the disease: an integrative revision of Latin American studies |
| Q38687386 | Screening Uptake Differences Are Not Implicated in Poorer Breast Cancer Outcomes among Singaporean Malay Women |
| Q45069214 | Sedentary time and postmenopausal breast cancer incidence |
| Q34604454 | Sexual dysfunction and infertility as late effects of cancer treatment |
| Q91713420 | Sphingosine Kinase 1 in Breast Cancer-A New Molecular Marker and a Therapy Target |
| Q41595188 | State of the evidence 2017: an update on the connection between breast cancer and the environment |
| Q33812240 | Structure-based virtual screening and molecular docking for the identification of potential multi-targeted inhibitors against breast cancer |
| Q38416366 | Suicide attempt and future risk of cancer: a nationwide cohort study in Sweden |
| Q38295108 | The 2014 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: triple-negative breast cancer |
| Q30234511 | The Association of CYP19A1 Variation with Circulating Estradiol and Aromatase Inhibitor Outcome: Can CYP19A1 Variants Be Used to Predict Treatment Efficacy? |
| Q35813007 | The Basic Facts of Korean Breast Cancer in 2012: Results from a Nationwide Survey and Breast Cancer Registry Database |
| Q64116004 | The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With or Mutations |
| Q58811095 | The association between age at menarche and later risk of gestational diabetes is mediated by insulin resistance |
| Q41497550 | The reproducibility of self-reported age at menarche: The Tromsø Study |
| Q58803134 | Trends in incidence, mortality and survival in women with breast cancer from 1985 to 2012 in Granada, Spain: a population-based study |
| Q35416463 | Tumor subtype-specific associations of hormone-related reproductive factors on breast cancer survival |
| Q31032088 | Use of exogenous hormones and the risk of breast cancer: results from self-reported survey data with validity assessment |
| Q50116117 | VSP-17, a New PPARγ Agonist, Suppresses the Metastasis of Triple-Negative Breast Cancer via Upregulating the Expression of E-Cadherin. |
| Q40123917 | Variability in DNA Repair Capacity Levels among Molecular Breast Cancer Subtypes: Triple Negative Breast Cancer Shows Lowest Repair |
Search more.